{
  "basic_info": {
    "symbol": "ONC",
    "name": "BeiGene, Ltd.",
    "sector": "LIFE SCIENCES",
    "industry": "PHARMACEUTICAL PREPARATIONS",
    "country": "USA",
    "currency": "USD"
  },
  "market_data": {
    "market_cap": "32928178000",
    "shares_outstanding": "99370000",
    "52_week_high": "308.87",
    "52_week_low": "158.84",
    "50_day_ma": "263.52",
    "200_day_ma": "232.53"
  },
  "valuation_ratios": {
    "pe_ratio": "None",
    "peg_ratio": "None",
    "price_to_book": "9.25",
    "price_to_sales": "7.89",
    "ev_revenue": "7.52",
    "ev_ebitda": "-"
  },
  "profitability_metrics": {
    "profit_margin": "-0.094",
    "operating_margin_ttm": "0.0099",
    "return_on_assets_ttm": "-0.0322",
    "return_on_equity_ttm": "-0.114",
    "gross_profit_ttm": "3541712000"
  },
  "financial_strength": {
    "revenue_ttm": "4175868000",
    "revenue_per_share_ttm": "39.41",
    "quarterly_revenue_growth": "0.486",
    "quarterly_earnings_growth": "0",
    "book_value": "32.42",
    "diluted_eps_ttm": "-3.65"
  },
  "dividend_info": {
    "dividend_per_share": "None",
    "dividend_yield": "None",
    "dividend_date": "None",
    "ex_dividend_date": "None"
  },
  "technical_indicators": {
    "beta": "0.284",
    "analyst_target_price": "336.42",
    "trailing_pe": "-",
    "forward_pe": "166.67"
  }
}